Altre lingue Jagsonpal Pharmaceuticals Limited

Azioni

JAGSNPHARM

INE048B01027

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:43:47 26/04/2024			Variaz. 5gg	Var. 1 gen.
343,6 ^INR	+3,06%		+7,97%	-11,66%

08/03	Jagsonpal Pharmaceuticals Limited lancia Queezy-ER®	CI
02/02	Jagsonpal Pharmaceuticals Limited riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Jagsonpal Pharmaceuticals Limited Launches Queezy-ER®	08/03
Jagsonpal Pharmaceuticals Limited Announces Chief Financial Officer Changes	02/02
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/02
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	03/11
Jagsonpal Pharmaceuticals' Net Profit Soars in Fiscal Q1	03/08/23
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	02/08/23
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23/05/23
Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23/05/23
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm and others completed the acquisition of 43.73% stake in Jagsonpal Pharmaceuticals Limited from Aresko Progressive Private Limited and Rajpal Singh Kochhar.	31/03/23
Jagsonpal Pharmaceuticals Limited Announces Appointment of Abhishek Joshi as Company Secretary and Compliance Officer	13/02/23
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/02/23
Jagsonpal Pharmaceuticals Limited Announces Executive Changes	31/12/22
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09/11/22
Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme	30/08/22
Jagsonpal Pharmaceuticals : Reply to Clarification Sought	16/08/22
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	09/08/22
Jagsonpal Pharmaceuticals : Appointment	16/07/22
Jagsonpal Pharmaceuticals Limited Announces Executive Changes	16/07/22
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm cancelled the acquisition of 26% stake in Jagsonpal Pharmaceuticals Limited.	20/06/22
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jagsonpal Pharmaceuticals Limited

Azioni

JAGSNPHARM

INE048B01027

Altre lingue

Filtri